Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery.
暂无分享,去创建一个
Tonglei Li | Richard A Gemeinhart | H. Weiss | B. Evers | R. Gemeinhart | B. Evers | M. Leggas | Tonglei Li | B Mark Evers | Christin P Hollis | Heidi L Weiss | Markos Leggas | Christin P. Hollis
[1] R. Weissleder,et al. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging , 2002, European Radiology.
[2] Jinming Gao,et al. Multifunctional Micellar Nanomedicine for Cancer Therapy , 2009, Experimental biology and medicine.
[3] M. Christian,et al. A reassessment of cardiac toxicity associated with Taxol. , 1993, Journal of the National Cancer Institute. Monographs.
[4] S. Lyons. Advances in imaging mouse tumour models in vivo , 2005, The Journal of pathology.
[5] Ting Song,et al. A review of imaging techniques for systems biology , 2008, BMC Systems Biology.
[6] P. Wei,et al. Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery , 2011, International journal of nanomedicine.
[7] Elaine Merisko-Liversidge,et al. Nanosizing: a formulation approach for poorly-water-soluble compounds. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[8] F. Liu,et al. Targeted cancer therapy with novel high drug-loading nanocrystals. , 2010, Journal of pharmaceutical sciences.
[9] Wenting Dai,et al. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions. , 2008, International journal of pharmaceutics.
[10] R. Müller,et al. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.
[11] C. Barbé,et al. Silica Particles: A Novel Drug‐Delivery System , 2004 .
[12] Ranjita Shegokar,et al. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. , 2010, International journal of pharmaceutics.
[13] Biodistribution Studies of Nanoparticles Using Fluorescence Imaging: A Qualitative or Quantitative Method? , 2012, Pharmaceutical Research.
[14] R K Jain,et al. Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.
[15] Joseph Wong,et al. Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat. , 2007, International journal of pharmaceutics.
[16] M. Tachibana,et al. Combination therapy with paclitaxel and thalidomide inhibits angiogenesis and growth of human colon cancer xenograft in mice. , 2003, Anticancer research.
[17] Philip Chi Lip Kwok,et al. Production methods for nanodrug particles using the bottom-up approach. , 2011, Advanced drug delivery reviews.
[18] D. Hammer,et al. Polymersomes: a new multi-functional tool for cancer diagnosis and therapy. , 2008, Methods.
[19] M. Bally,et al. Designing Liposomal Anticancer Drug Formulations for Specific Therapeutic Applications , 2000 .
[20] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[21] R. Jain,et al. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. , 1991, Cancer research.
[22] H. Maeda. Nitroglycerin enhances vascular blood flow and drug delivery in hypoxic tumor tissues: analogy between angina pectoris and solid tumors and enhancement of the EPR effect. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[23] Rakesh K Jain,et al. Molecular regulation of vessel maturation , 2003, Nature Medicine.
[24] Kwangmeyung Kim,et al. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[25] M. Frank,et al. The role of complement in inflammation and phagocytosis. , 1991, Immunology today.
[26] D M Shames,et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. , 1998, AJR. American journal of roentgenology.
[27] Chao-Yu Zhang,et al. Pharmacokinetic evaluation and antitumor activity of 2-methoxyestradiol nanosuspension , 2012, Drug development and industrial pharmacy.
[28] M. Egorin,et al. Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice , 2004, Cancer Chemotherapy and Pharmacology.
[29] Nicholas A Peppas,et al. Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers. , 2011, Accounts of chemical research.
[30] R. Jain,et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[31] Jun Fang,et al. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.
[32] Dong Liang,et al. Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles , 2009, Nanotechnology.
[33] Kinam Park. Nanotechnology: What it can do for drug delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[34] Tonglei Li,et al. Hybrid nanocrystals: achieving concurrent therapeutic and bioimaging functionalities toward solid tumors. , 2011, Molecular pharmaceutics.
[35] Beom Suk Lee,et al. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[36] R K Jain,et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.
[37] J. Beijnen,et al. Tissue distribution, metabolism and excretion of paclitaxel in mice , 1996, Anti-cancer drugs.
[38] Ralph Weissleder,et al. Near-infrared fluorescence: application to in vivo molecular imaging. , 2010, Current opinion in chemical biology.
[39] D. Mager,et al. Meta-analysis of Nanoparticulate Paclitaxel Delivery System Pharmacokinetics and Model Prediction of Associated Neutropenia , 2012, Pharmaceutical Research.
[40] R. Weissleder,et al. Tomographic fluorescence mapping of tumor targets. , 2005, Cancer research.
[41] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[42] Kostas Kostarelos,et al. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. , 2011, Accounts of chemical research.
[43] Kinam Park,et al. Targeted drug delivery to tumors: myths, reality and possibility. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[44] R. Govindan,et al. Novel formulations of taxanes: a review. Old wine in a new bottle? , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[45] Nicholas A Peppas,et al. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.
[46] Sanjay Garg,et al. Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery. , 2009, International journal of pharmaceutics.
[47] Si-Yang Song,et al. Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals. , 2012, International journal of pharmaceutics.
[48] Ick Chan Kwon,et al. Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links. , 2012, Biomaterials.
[49] Mandip Singh,et al. Lipophilic drug derivatives in liposomes , 1998 .
[50] Xunbin Wei,et al. pH‐Activated Near‐Infrared Fluorescence Nanoprobe Imaging Tumors by Sensing the Acidic Microenvironment , 2010 .
[51] H. Maeda. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. , 2001, Advances in enzyme regulation.
[52] Kwangmeyung Kim,et al. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles. , 2012, Biomaterials.